Canopy Growth Corp represents values of innovation, integrity, and sustainability. With a corporate philosophy centered on advancing the global cannabis industry, the company strives to drive positive change through responsible cultivation, research, and development. Canopy Growth Corp embraces a commitment to producing high-quality, diverse cannabis products that meet the evolving needs of consumers worldwide. With a focus on transparency and compliance, the company fosters a culture of accountability and ethical practices. By prioritizing sustainability and social responsibility, Canopy Growth Corp aims to create lasting value for its stakeholders and contribute to the growth and acceptance of the cannabis sector.

Canopy Growth Corp is primarily present in several countries and regions around the world. The company has established a significant presence in Canada, where it is headquartered and operates numerous production facilities and retail locations. Additionally, Canopy Growth Corp has expanded its operations to include the United States, with a focus on the growing legal cannabis market. The company has also established a presence in Europe, particularly in Germany and the United Kingdom, where it has acquired various licenses and formed partnerships to distribute and market its products.

Canopy Growth Corp has achieved several significant milestones in its corporate history. One notable milestone was becoming the first cannabis company to be listed on the New York Stock Exchange and the Toronto Stock Exchange in 2018. The company has also established itself as a global leader in the cannabis industry, expanding its operations in multiple countries and entering strategic partnerships with well-known brands like Constellation Brands. Additionally, Canopy Growth Corp has made substantial investments in research and development, leading to innovation in cannabis cultivation and product development. These milestones have solidified Canopy Growth Corp's position as a prominent player in the evolving cannabis market.

Canopy Growth Corp, a prominent Canadian cannabis company, has a rich history and background. Established in 2013, Canopy Growth quickly emerged as a frontrunner in the cannabis industry. The company's founder, Bruce Linton, played a pivotal role in its development. Canopy Growth became the first cannabis producer to be listed on the Toronto Stock Exchange in 2014. With headquarters in Smiths Falls, Ontario, the company focuses on cultivating, producing, and distributing high-quality cannabis products for both medical and recreational use. Canopy Growth has gained global recognition and expanded its operations to various countries, making it one of the most influential players in the cannabis market.

Some of the main competitors of Canopy Growth Corp in the market include Aurora Cannabis, Cronos Group, and Tilray.

Canopy Growth Corp is primarily active in the cannabis industry.

Canopy Growth Corp operates in the cannabis industry and is focused on producing, cultivating, and selling cannabis and hemp products. The company's business model revolves around being a vertically integrated cannabis company, encompassing cultivation, processing, branding, and retailing. Canopy Growth Corp aims to capitalize on the growing demand for cannabis products and aims to provide a diverse range of high-quality cannabis products to both medical and recreational markets globally. With their extensive portfolio of brands and partnerships, Canopy Growth Corp strives to establish itself as a dominant player in the rapidly expanding cannabis market.

Det Canopy Growth P/E-forhold er -0,70.

Canopy Growth KUV er 1,54.

AlleAktien Kvalitetsscore for Canopy Growth er 3/10.

Den Canopy Growth omsætning er 297,15 mio. CAD.

Den Canopy Growth indtjening er -657,27 mio. CAD.

The Canadian company Canopy Growth Corp was founded in 2013 and has become a leading company in the production and marketing of medical cannabis and recreational marijuana. The business model consists of various divisions that focus on the production, sale, and research of cannabis. Production: Canopy Growth Corp owns several production facilities in Canada where they cultivate and harvest various marijuana strains. The production facilities are equipped with state-of-the-art equipment and technologies to ensure the highest quality of cannabis. The company also has partnerships with other companies to ensure the worldwide delivery of cannabis. Sale: Canopy Growth Corp has developed its own brand of medical cannabis called Spectrum Therapeutics, which is available in Canada and other countries. The products range from dried flowers to oils and capsules. Additionally, the company has also developed a brand called Tweed, which focuses on the recreational market. Tweed offers various marijuana strains in different forms such as vapes, edible cannabis, and dried flowers. Research: Canopy Growth Corp has a research and development department that focuses on the development of new cannabis products. The company works closely with other scientists and researchers to study the effects of cannabis on various health conditions. They also have a partner program called Canopy Rivers, which allows other companies to invest in the cannabis industry. It is important to emphasize that Canopy Growth Corp has a close partnership with the alcoholic beverage manufacturer Constellation Brands. Constellation Brands invested about $4 billion in Canopy Growth Corp in 2018. The two companies work together to introduce new products to the market that contain both alcoholic beverages and cannabis. Canopy Growth Corp is a major player in the global market for medical cannabis and recreational marijuana. The company has a clear vision to study the effects of cannabis on various health conditions and develop new products. The partnership with Constellation Brands also shows the interest of major companies in the cannabis industry. In Germany, Canopy Growth Corp has a subsidiary called Spektrum Cannabis GmbH, which distributes medical cannabis in the German market. The products are only available by prescription and are delivered by various pharmacies in Germany. Canopy Growth Corp also advocates for the legalization of medical cannabis in other countries to facilitate access for patients. The company Canopy Growth Corp is a leading company in the production and marketing of medical and recreational marijuana. They have production facilities in Canada and partnerships with other companies for worldwide delivery. They have their own brands for medical cannabis (Spectrum Therapeutics) and recreational marijuana (Tweed). They also have a research and development department focusing on developing new cannabis products and work with other scientists and researchers. Canopy Growth Corp has a partnership with Constellation Brands, a major alcoholic beverage manufacturer, to develop products that combine alcohol and cannabis. In Germany, they have a subsidiary called Spektrum Cannabis GmbH that distributes medical cannabis. They are also advocating for the legalization of medical cannabis in other countries.

Canopy Growth udbetaler et udbytte på 0 CAD fordelt over udbetalinger om året.

Udbyttet kan for nuværende ikke beregnes for Canopy Growth, eller selskabet udbetaler ikke udbytte.

ISIN'en for Canopy Growth er CA1380351009.

WKN for Canopy Growth er A140QA.

Tickeren for Canopy Growth er WEED.TO.

I løbet af de sidste 12 måneder betalte Canopy Growth en dividende på . Dette svarer til et dividendeudbytte på omkring . For de kommende 12 måneder vil Canopy Growth sandsynligvis betale en dividende på 0 CAD.

Udbytteafkastet for Canopy Growth er i øjeblikket .

Canopy Growth betaler kvartalsvis udbytte. Dette uddeles i månederne .

Canopy Growth betalte udbytte hvert år i løbet af de sidste 0 år.

For de kommende 12 måneder forventes der dividender på 0 CAD. Dette svarer til et dividendeafkast på 0 %.

Canopy Growth bliver tildelt sektoren 'Sundhed'.

For at modtage det seneste udbytte på Canopy Growth fra den 28.9.2024 på 0 CAD, skulle du have haft aktien i din portefølje før ex-datoen den 28.9.2024.

Udbetalingen af det sidste udbytte blev foretaget den 28.9.2024.

I løbet af 2023 udbetalte Canopy Growth 0 CAD i form af dividender.

Udbytterne fra Canopy Growth udbetales i CAD.